Igor Bilinsky
CIK: 0001594604
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IOVANCE BIOTHERAPEUTICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (34 total)
- Sep 8, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct4K shares at avg. $8.70$35K - Sep 8, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct7.8K shares- - Sep 1, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct4.5K shares at avg. $8.28$37K - Sep 1, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct8.8K shares- - Jun 5, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct7.8K shares- - Jun 5, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct4K shares at avg. $4.23$17K - Jun 1, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct4.5K shares at avg. $3.96$18K - Jun 1, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct8.8K shares- - Mar 9, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Award(A)DirectRestricted Stock Units
117.5K shares- - Mar 5, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct16.6K shares at avg. $4.58$76K - Mar 5, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct31.2K shares- - Mar 2, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct12.3K shares- - Mar 2, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct6.9K shares at avg. $3.79$26K - Dec 2, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct1.8K shares at avg. $2.14$4K - Dec 2, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct3.5K shares- - Dec 1, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct4.5K shares at avg. $2.23$10K - Dec 1, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct8.8K shares- - Sep 2, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct12.3K shares- - Sep 2, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct6.3K shares at avg. $2.19$14K - Jun 2, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct6.3K shares at avg. $1.76$11K - Jun 2, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct12.3K shares- - Mar 5, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Award(A)DirectRestricted Stock Units
93.8K shares- - Mar 3, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax Payment(F)Direct33.3K shares at avg. $4.04$135K - Mar 3, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct62.1K shares- - Jan 14, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Exercise(M)Direct2.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 8, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 3,976 | $8.70 | $34,591 | Direct |
| Sep 8, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 7,813 | - | $0 | Direct |
| Sep 1, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 4,472 | $8.28 | $37,028 | Direct |
| Sep 1, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 8,789 | - | $0 | Direct |
| Jun 5, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 7,813 | - | $0 | Direct |
| Jun 5, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 3,976 | $4.23 | $16,818 | Direct |
| Jun 1, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 4,473 | $3.96 | $17,713 | Direct |
| Jun 1, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 8,790 | - | $0 | Direct |
| Mar 9, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Award(A) Restricted Stock Units | 117,500 | - | - | Direct |
| Mar 5, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 16,628 | $4.58 | $76,156 | Direct |
| Mar 5, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 31,246 | - | $0 | Direct |
| Mar 2, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 12,307 | - | $0 | Direct |
| Mar 2, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 6,903 | $3.79 | $26,162 | Direct |
| Dec 2, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 1,786 | $2.14 | $3,822 | Direct |
| Dec 2, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 3,516 | - | - | Direct |
| Dec 1, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 4,464 | $2.23 | $9,955 | Direct |
| Dec 1, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 8,789 | - | - | Direct |
| Sep 2, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 12,306 | - | - | Direct |
| Sep 2, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 6,250 | $2.19 | $13,688 | Direct |
| Jun 2, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 6,250 | $1.76 | $11,000 | Direct |
| Jun 2, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 12,305 | - | - | Direct |
| Mar 5, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Award(A) Restricted Stock Units | 93,750 | - | - | Direct |
| Mar 3, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment(F) | 33,302 | $4.04 | $134,540 | Direct |
| Mar 3, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 62,106 | - | - | Direct |
| Jan 14, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise(M) | 2,813 | - | $0 | Direct |
1-25 of 34 transactions
About BILINSKY IGOR
BILINSKY IGOR (SEC CIK 0001594604) files insider reports with the SEC as Chief Operating Officer of IOVANCE BIOTHERAPEUTICS, INC. (IOVA).
Signal8 holds 16 ownership filings by BILINSKY IGOR, all Form 4s, filed between Sep 5, 2024 and Sep 10, 2026. Those filings report 34 transactions, from Sep 3, 2024 to Sep 8, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on BILINSKY IGOR's filings is in SAN CARLOS, CA.
Recent filings by BILINSKY IGOR
- Sep 8, 2026: Tax withholding of IOVA shares (Form 4, code F).
- Sep 8, 2026: Option exercise of IOVA shares (Form 4, code M).
- Sep 1, 2026: Tax withholding of IOVA shares (Form 4, code F).
- Sep 1, 2026: Option exercise of IOVA shares (Form 4, code M).
- Jun 5, 2026: Option exercise of IOVA shares (Form 4, code M).
Other insiders filing for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
- Berkowitz Noah, Chief Medical Officer
- Vogt Frederick G, Interim CEO & General Counsel
- Puri Raj K., Chief Regulatory Officer
- Kirby Daniel Gordon, Chief Commercial Officer
- Roche Corleen M., Chief Financial Officer
- WEISER MICHAEL, Director